Verified peer comparison
Inhibrx Biosciences vs Scinai Immunotherapeutics Financial Comparison
Direct answer
Inhibrx Biosciences and Scinai Immunotherapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Inhibrx Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Inhibrx Biosciences Revenue
- 1,300,000 USD
- Scinai Immunotherapeutics Revenue
- 1,311,000 USD
- Inhibrx Biosciences Operating income
- -135,025,000 USD
- Scinai Immunotherapeutics Operating income
- -7,542,000 USD